Topical intranasal ioxaglate meglumine 39.3% and ioxaglate sodium 19.6% (Hexabrix) reduces the acute response to nasal challenge with allergen

Shilpa Vishwanath; Fuad M. Baroody; Mohamad R. Chaaban; Marcella Detineo; Kenneth H. Lasser; Elliot C. Lasser; Robert M. Naclerio

doi:10.1016/j.jaci.2011.02.024

Topical intranasal ioxaglate meglumine 39.3% and ioxaglate sodium 19.6% (Hexabrix) reduces the acute response to nasal challenge with allergen

Shilpa Vishwanath, Fuad M. Baroody, Mohamad R. Chaaban, Marcella Detineo, Kenneth H. Lasser, Elliot C. Lasser, Robert M. Naclerio

Research output: Contribution to journal › Article › peer-review

2 Scopus citations

Original language	English (US)
Pages (from-to)	219-221
Number of pages	3
Journal	Journal of Allergy and Clinical Immunology
Volume	128
Issue number	1
DOIs	https://doi.org/10.1016/j.jaci.2011.02.024
State	Published - Jul 2011
Externally published	Yes

ASJC Scopus subject areas

Immunology and Allergy
Immunology

Access to Document

10.1016/j.jaci.2011.02.024

Cite this

@article{00448a4b71744bbaa5e8203dd2763cd9,

title = "Topical intranasal ioxaglate meglumine 39.3% and ioxaglate sodium 19.6% (Hexabrix) reduces the acute response to nasal challenge with allergen",

author = "Shilpa Vishwanath and Baroody, {Fuad M.} and Chaaban, {Mohamad R.} and Marcella Detineo and Lasser, {Kenneth H.} and Lasser, {Elliot C.} and Naclerio, {Robert M.}",

year = "2011",

month = jul,

doi = "10.1016/j.jaci.2011.02.024",

language = "English (US)",

volume = "128",

pages = "219--221",

journal = "Journal of Allergy and Clinical Immunology",

issn = "0091-6749",

publisher = "Mosby Inc.",

number = "1",

}

TY - JOUR

T1 - Topical intranasal ioxaglate meglumine 39.3% and ioxaglate sodium 19.6% (Hexabrix) reduces the acute response to nasal challenge with allergen

AU - Vishwanath, Shilpa

AU - Baroody, Fuad M.

AU - Chaaban, Mohamad R.

AU - Detineo, Marcella

AU - Lasser, Kenneth H.

AU - Lasser, Elliot C.

AU - Naclerio, Robert M.

PY - 2011/7

Y1 - 2011/7

UR - http://www.scopus.com/inward/record.url?scp=79959844408&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79959844408&partnerID=8YFLogxK

U2 - 10.1016/j.jaci.2011.02.024

DO - 10.1016/j.jaci.2011.02.024

M3 - Article

C2 - 21414657

AN - SCOPUS:79959844408

SN - 0091-6749

VL - 128

SP - 219

EP - 221

JO - Journal of Allergy and Clinical Immunology

JF - Journal of Allergy and Clinical Immunology

IS - 1

ER -

Topical intranasal ioxaglate meglumine 39.3% and ioxaglate sodium 19.6% (Hexabrix) reduces the acute response to nasal challenge with allergen

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this